Marex Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Sell
4,330
-1,739
-29% -$517K 0.01% 396
2025
Q4
$1.66M Sell
6,069
-5,159
-46% -$1.4M 0.01% 337
2025
Q3
$3.03M Buy
+11,228
New +$3.05M 0.02% 226
2025
Q2
Sell
-23,362
Closed -$6.2M 703
2025
Q1
$6.2M Buy
23,362
+405
+2% +$99.9K 0.12% 94
2024
Q4
$5.33M Sell
22,957
-2,422
-10% -$557K 0.09% 96
2024
Q3
$5.6M Sell
25,379
-99,902
-80% -$20.7M 0.13% 90
2024
Q2
$24.6M Buy
125,281
+100,660
+409% +$20.8M 0.66% 36
2024
Q1
$5.3M Buy
24,621
+524
+2% +$110K 0.17% 81
2023
Q4
$5.07M Buy
+24,097
New +$5.14M 0.2% 91

Other funds holding CME

Marex Group's CME Position: Q1 2026 in Review

Marex Group reduced its CME Group (CME) stake by 29% in Q1 2026, selling an estimated $517K and leaving 4,330 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #396.

Marex Group first reported a position in CME in Q4 2023 and has held it in 9 quarters since. The position peaked at $24.6M in Q2 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Marex Group held 4,330 shares of CME Group worth $1.28M as of Q1 2026.
  • Marex Group sold 1,739 CME Group shares in Q1 2026, an estimated $517K.
  • CME Group made up 0.01% of Marex Group's portfolio in Q1 2026, its #396 holding.
  • Marex Group first reported a position in CME Group in Q4 2023 and has held it in 9 quarters since.
  • Marex Group's CME Group position peaked at $24.6M in Q2 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.